Core Insights - The article highlights the advancements in medical imaging technology, particularly in cancer diagnosis and treatment, showcasing the integration of AI in medical devices [1][3][5] Group 1: Medical Device Innovations - Current CT and MRI devices provide comprehensive cancer diagnosis and treatment solutions, enabling minimally invasive and non-invasive procedures [3] - Siemens Healthineers showcased a DSA angiography device with sub-millimeter spatial resolution, capable of capturing previously undetectable lesions in just 2.5 seconds, incorporating AI technologies developed by local teams [3] - Medtronic introduced a newly FDA-approved ultra-hard guidewire, enhancing the stability and predictability of transcatheter aortic valve replacement (TAVR) procedures, with plans to enter the Chinese market [3] Group 2: AI Integration in Healthcare - The Chinese government emphasizes the development of artificial intelligence, providing strong momentum for the digital transformation of the healthcare industry [5] - Many medical companies at the expo established AI zones, presenting AI surgical solutions, with Siemens demonstrating innovations in AI-driven medical transformations [5] - Medtronic plans to launch a localized AI solution for TAVR procedures, developed in collaboration with local doctors and AI firms, aiming to create a comprehensive treatment chain [5][6] Group 3: Localized Product Development - Karl Storz introduced a second batch of domestically produced products, including cold light sources and pneumoperitoneum machines, promoting day surgery through minimally invasive techniques [4] - The company set up simulation units for outpatient bladder endoscopy and gynecological procedures, demonstrating resource optimization in hospitals [4] Group 4: Future Directions - Siemens aims to integrate AI with diagnostic imaging and adaptive radiotherapy, enhancing treatment precision and efficiency while reducing complications [6] - Medtronic is increasing investment in local AI and healthcare R&D, establishing a digital medical innovation base focused on cardiovascular, minimally invasive surgery, and neuroscience [6]